Cooperative Agreement NU51IP000929
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $1,351,924 to The Regents of the University of California, San Francisco (UCSF) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to characterize interactions between human and vector behaviors in order to enhance malaria control interventions in Uganda. The project, which commenced August 11, 2025, and extends through July 31, 2030, addresses the stalled progress in...
- Federal Project Grant Award Summary Makerere University College of Health Sciences received a $780,437 Project Grant from the Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989), awarded August 1, 2025, with a completion date of March 31, 2030. The grant supports "Scaling Up Advanced Genomics and Bioinformatics Research Training in Pediatric HIV/AIDS in Uganda," addressing the substantial burden of HIV/AIDS in Africa through...
- Federal Grant Award Summary The Fogarty International Center awarded Makerere University College of Health Sciences a $303,316 Project Grant on September 15, 2025, under the International Research and Research Training program (CFDA 93.989) to implement the H-DATA (Harnessing Health Data Science Capacity to Strengthen Evidence-Based Interventions, Policy and Response to the HIV/AIDS Epidemic in Uganda) initiative. The grant supports a comprehensive training program designed to equip Ugandan...
- Federal Cooperative Agreement Summary The Animal and Plant Health Inspection Service (APHIS) awarded a $1,998,388 Cooperative Agreement to The Trustees of Columbia University in the City of New York on February 2, 2026, under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025). The award funds a three-year research initiative (completion February 1, 2029) to evaluate far-ultraviolet (far-UVC) lighting at 222 nanometers as a novel intervention technology to prevent...
- Cooperative Agreement Summary St. Jude Children's Research Hospital Inc. received a $1,943,621 Cooperative Agreement from the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025), effective February 2, 2026, through January 31, 2029. The award supports integrated field and laboratory research to investigate novel transmission mechanisms of High Pathogenicity Avian Influenza...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2,074,701 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Emory University. The project, titled "Drivers of Influenza A Virus Transmission in Humans," aims to address gaps in understanding the biological and physical processes underlying the transmission of influenza A virus in humans. The key objectives are to: 1) Define the dynamics of viral load, immunological...
- Federal Grant Award Summary The National Science Foundation's Division of Behavioral and Cognitive Sciences awarded the University of North Carolina at Chapel Hill a $496,076 Project Grant (Social, Behavioral, and Economic Sciences program, CFDA 47.075) effective October 1, 2025, through September 30, 2028, to investigate the geographic, genetic, and ecological drivers of H5N1 avian influenza transmission and evolution in the United States. The primary deliverable is a publicly accessible...
- Federal Cooperative Agreement Summary The University of Georgia Research Foundation, Inc. received a $1.79 million Cooperative Agreement from the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025), effective February 2, 2026, through February 1, 2029. This agreement supports research to develop natural compound-based oral prophylactic interventions against highly pathogenic...
- Federal Cooperative Agreement Summary The University of Georgia Research Foundation, Inc. received a $1,999,873 Cooperative Agreement from the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025), awarded February 2, 2026, with completion targeted for February 1, 2029. The project addresses the urgent threat of highly pathogenic avian influenza (HPAI) to the U.S. poultry...
- Federal Cooperative Agreement Summary The University of Nebraska received a $1.42 million Cooperative Agreement from the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025), awarded February 2, 2026, with a completion date of February 1, 2028. The project enhances surveillance capabilities for Highly Pathogenic Avian Influenza (HPAI) in poultry and wild birds by developing...
SURVEILLANCE AND RESPONSE TO AVIAN AND PANDEMIC INFLUENZA IN UGANDA - PROJECT SUMMARYTHE IMPACT OF INFLUENZA INFECTION IN AFRICA IS NOT VERY WELL DOCUMENTED. HOWEVER, THE INFORMATION AVAILABLE SHOWS THAT INFLUENZA HAS A SIGNIFICANT IMPACT ON MORBIDITY AND MORTALITY. IN THE REGION, INFLUENZA VIRUSES ARE IMPORTANT RESPIRATORY PATHOGENS, AND ACUTE RESPIRATORY TRACT INFECTIONS, SUCH AS PNEUMONIA, ARE A MAJOR CAUSE OF DEATH, PARTICULARLY AMONG CHILDREN. IN SUB-SAHARAN AFRICA, MOST OUTBREAKS OF INFLUENZA GO UNREPORTED AND INFORMATION ABOUT CIRCULATING STRAINS IS RELATIVELY LIMITED. ALTHOUGH INFLUENZA HAS BEEN WIDELY STUDIED IN DEVELOPED COUNTRIES, LITTLE IS KNOWN ABOUT ITS EPIDEMIOLOGY, SEASONALITY, AND BURDEN IN DEVELOPING COUNTRIES. IN 2006 FUNDING WAS OBTAINED FROM THE US DEPARTMENT OF HEALTH AND HUMAN SERVICES INFLUENZA BRANCH IN ATLANTA, TO ESTABLISH AN INFLUENZA SURVEILLANCE PROGRAM AND DIAGNOSTIC CENTER IN UGANDA. INFLUENZA SURVEILLANCE ACTIVITIES WERE STARTED, AND THE UGANDA NATIONAL INFLUENZA CENTER (NIC) WAS REINSTATED AT UGANDA VIRUS RESEARCH INSTITUTE. OVER THE PERIOD OF FIFTEEN YEARS, INFLUENZA SURVEILLANCE IN UGANDA HAS BEEN WELL ESTABLISHED. THROUGH THIS PROGRAM, SURVEILLANCE CAPACITIES, AND LABORATORY VIROLOGICAL AND EPIDEMIOLOGICAL CAPACITIES HAVE BEEN DEVELOPED, NOT ONLY FOR INFLUENZA BUT FOR OTHER DISEASES TOO. IT IS CRITICAL THAT THESE CAPACITIES CONTINUE TO BE SUSTAINED AND STRENGTHENED TO ENSURE AN EFFECTIVE NATIONAL SURVEILLANCE BUT ALSO TO PARTICIPATE IN THE GLOBAL DETECTION AND RESPONSE TO PANDEMIC INFLUENZA. THIS PROGRAM IS BENEFICIAL AS IT GENERATES INFORMATION FOR USE IN REDUCING THE MORBIDITY AND MORTALITY ASSOCIATED WITH INFLUENZA AND OTHER RESPIRATORY INFECTIONS. THE PROGRAM WILL COMMUNICATE DATA ON A WEEKLY BASIS TO THE WHO GLOBAL INFLUENZA SURVEILLANCE AND RESPONSE SYSTEM (GISRS), FLUNET AND FLUID, AND ALSO PROVIDE ISOLATES OF INFLUENZA VIRUS TO THE ATLANTA WHO CC FOR FURTHER DIAGNOSIS AND USE IN VACCINE PRODUCTION.THE PURPOSE OF THIS REQUEST FOR FUNDING IS TO ENABLE UGANDA, THROUGH THE UVRI NATIONAL INFLUENZA CENTER, TO CONTRIBUTE TOWARDS THE PREVENTION AND CONTROL OF INFLUENZA EPIDEMICS AND PANDEMICS BY MAINTAINING AND IMPROVING THE EXISTING ROUTINE INFLUENZA SENTINEL SURVEILLANCE SYSTEM AND DEVELOP CAPACITY TO MONITOR AND QUICKLY RESPOND TO HIGHLY PATHOGENIC VIRUSES AND BACTERIA TRANSMISSIBLE AMONG HUMANS (FROM ANIMALS), AS WELL AS IDENTIFY OUTBREAKS OF SEVERE RESPIRATORY ILLNESS SYNDROMES. ASSESSMENTS AND EVALUATIONS WILL BE CONDUCTED TO GET INFORMATION ON GAPS AND WHERE THERE IS NEED FOR IMPROVEMENTS. THE IDENTIFIED OUTBREAKS WILL BE RESPONDED TO USING A ONE HEALTH MODEL. COMMUNICATION BETWEEN THE MINISTRIES OF HEALTH, MINISTRY OF AGRICULTURE, ANIMAL INDUSTRIES, AND FORESTRY, MINISTRY OF WATER AND ENVIRONMENT AND THE UGANDA WILDLIFE AUTHORITY WILL BE IMPROVED AND PLANS, AND MOUS WILL BE DEVELOPED FOR WORKING TOGETHER ON SURVEILLANCE DISEASE INVESTIGATIONS. THE NATIONAL ONE HEALTH PLATFORM WILL PROVIDE A CHANNEL FOR COMMUNICATION. A TOTAL AMOUNT OF US $ 249,955.00 REQUESTED TO FACILITATE THE ACTIVITIES OF THE THREE COMPONENTS (US $ 140.000 FOR COMPONENT 1; US $ 59,955 FOR COMPONENT 2; AND US $ 50,000 FOR COMPONENT 3.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $50.0k | 8/19/25 | ||
| Not listed | $0 | 11/18/24 | ||
| Not listed | $0 | 11/18/24 | ||
| Not listed | $140.0k | 6/26/24 | ||
| Not listed | $100.0k | 6/26/24 |